Advertisement

Topics

Johnson & Johnson Wins Reversal Of First St. Louis Talc-Cancer Verdict

00:12 EDT 18 Oct 2017 | FinanzNachrichten

NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) won its appeal of a $72 million verdict claiming its talc products cause ovarian cancer, as a Missouri appeals court found the case shouldn't have...

Related Biotechnology, Pharmaceutical and Healthcare News

Original Article: Johnson & Johnson Wins Reversal Of First St. Louis Talc-Cancer Verdict

NEXT ARTICLE

More From BioPortfolio on "Johnson & Johnson Wins Reversal Of First St. Louis Talc-Cancer Verdict"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...


News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches


BioPortfolio Limited Social Media
Publish Content Agreements
Tools Help

HON Code certificate This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com.
All rights reserved. All other trademarks recognized. Copyright © 1997-2017 BioPortfolio Limited. Site developed by Alacrify Ltd.